The impact of hepatitis C virus (HCV) RNA levels on immune status in chronically HCV mono-infected when compared to HIV/HCV co-infected on antiretroviral therapy 
| INTRODUCTION
Hepatitis
6
A number of studies support that HCV viraemia is associated with both immune activation and subsequent gradual loss of immune function. 7 A number of reports show that in chronic HCV infection, HCV-specific cytotoxic T lymphocytes have impaired or exhausted proliferative, cytokine and cytotoxic effector functions. [8] [9] [10] [11] [12] Natural killer (NK) cell activity has also been described to be decreased 13 as a result of several mechanisms including direct interaction of the viral protein E2 with surface CD81 on NK cells, 14 hepatocyte reduction of type 1 interferon (IFN) production via protein kinase R inactivation, 15, 16 greater stabilization of hepatocyte major histocompatibility complex-I molecules 17 and early inhibition of activation and IFN-γ production by NK cells. 14 Other mechanisms of immune dysfunction include decreased dendritic cell (DC) frequencies, impairment of the antigen-presenting function of DCs, 18-21 direct impairment of plasmacytoid DC (PDC) function by HCV core protein via increased interleukin-10 and reduced production of interleukin-12 and IFN-α.
22,23
Similar to HCV infection, HIV infection also leads to increased T-cell activation, 24 and functional impairment, 25 which is partially restored by antiretroviral therapy (ART). 26, 27 The impact of HIV on the natural course of HCV infection is deleterious with higher HCV viral load (vl), higher rate of HCV persistence and a higher risk of mortality or comorbidities than HCV-mono-infected patients. 5, 28 On the other hand, some studies also support a significant effect of HCV infection on the progression of HIV to acquired immune deficiency syndromedefining illness and related mortality. [29] [30] [31] [32] [33] [34] HIV/HCV-co-infected subjects have been described to retain high levels of immune activation that persist after ART-mediated HIV suppression, [35] [36] [37] [38] yet the role of HCV viraemia in driving persistent immune activation and/or its relationship to innate immune reconstitution after ART remains unknown.
Little is known about the additive effect of ART-treated HIV coinfection and HCV vl on innate and adaptive immune status in subjects with untreated chronic HCV infection. To address these questions, we used freshly obtained blood and peripheral blood mononuclear cells (PBMCs) for the characterization of adaptive and innate cells subsets, activation/exhaustion and innate signalling and function in HIV/HCVco-infected and HCV-mono-infected subjects.
| MATERIALS AND METHODS

| Participants
A total of 33 untreated HCV viraemic mono-infected (HCV monoinfected) and 45 ART-treated HIV-co-infected/untreated HCV viraemic (HIV/HCV-co-infected) subjects were studied. Clinical pa- 
| Whole-blood-based phenotypic characterization of immune subsets
To assess adaptive and innate cell subsets, same-day whole-blood seven-colour staining was performed as previously described 39 using the combinations of directly fluorochrome-conjugated anti-human cell surface monoclonal Abs shown in Table S1 . 
| Assessment of intracellular IFN-γ cytokine production in NK cells following effector cells/target interactions
To study functional NK target cell interaction within the context of cell-specific measures on NK subsets, constitutive and target-induced cytokine production (IFN-γ) in the presence or absence of in vitro stimulation was measured using flow cytometry. Briefly, fresh PBMC 
| Assessment of direct cytotoxicity against a MHC-null cancer target cell line
The standard
51
Cr release assay was used as previously described to assess constitutive and in vitro-induced NK cell-mediated cytotoxicity, using fresh PBMC preparations as effectors cells against the tumour-derived erythroblastoid MHC-null cell line K562.
42
Briefly, fresh PBMC were treated for 18 hours at 37°C with media alone or in vitro IFN-α (5000 U/mL, PBL). K562 cells, which served as targets, were labelled with Na 
| Statistical analysis
| RESULTS
| Study subjects demographics
Demographic and clinical characteristics of the study subjects are shown in Table 1 . A total of five of 45 HIV/HCV-co-infected subjects had HIV vl >400 copies/mL suggesting lack of ART-mediated suppression in a minority of the HIV/HCV-co-infected subjects. Interestingly, 22 of 45 HIV/HCV-co-infected subjects had CD4 + T-cell count <400 cells/mm 3 , with only two of 22 having HIV vl >400 copies/mL, suggesting lack of complete immune re-constitution in about one of two of the HIV/HCV-co-infected subjects, that was not associated with lack of HIV suppression. Finally, no significant difference was observed between the two groups for plasma levels of liver enzymes (alanine aminotransferase, aspartate aminotransferase).
| Higher levels of T-cell activation/ exhaustion and lower levels of Tregs in HIV/HCVco-infected subjects
HIV infection leads to increased T-cell activation, 24 to HCV-mono-infected subjects. Unadjusted data were also consistent with higher expression of exhaustion markers (ie CD160, BTLA/ CD160 and CTLA-4) on CD8 + T cells. In contrast, HIV/HCV-coinfected subjects had lower frequencies of CD3 + CD4 + T cells (P<.001) and Tregs (P=.02) when compared to HCV-mono-infected subjects (Table 2 , Figure 1, Fig. S1 ).
| Higher levels of innate activation and constitutive STAT-1 phosphorylation and lower NK function in HIV/HCV-co-infected subjects
While total frequency of NK and myeloid cell subsets examined (MDC, PDC, CD14 subsets) did not differ between groups, we document that constitutive STAT-1 phosphorylation was significantly higher on NK cells (P=.05) and monocytes (P=.02) in HIV/HCV-co-infected subjects when compared to HCV-mono-infected subjects (Table 2, Figure 2 ). (Table 2) .
Overall, innate markers of activation and function as listed in Table 2 support the interpretation of higher constitutive STAT-1-mediated activation in both monocyte and NK cells in spite of lower NK cytotoxicity in HIV/HCV-co-infected subjects as compared to HCV mono-infected.
| HIV co-infection affects the relationship between HCV vl and NK cell function
We assessed the effect of HCV vl and HIV co-infection on selected variables using multivariate linear regression models. The results of this analysis are summarized in Table 3 and Figure 3 . Briefly, when the effect of HCV vl and patient group was assessed independently (model 1) , of all the variables tested, only CD81 expression on NK cells ( 
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HIV/HCV-co-infected subjects than in HCV-mono-infected subjects (Table 3 , Figure 3) . Models assessing the effect of CD4 + T-cell count showed that HIV co-infection, but not CD4 + T-cell count, had a significant effect on T-cell activation/exhaustion, with CD38 (P=.001), BTLA (P=.03) and CD160 (P=.01) expression on CD8 + T cells being higher, and Tregs levels (P=.01) being lower in HIV/HCV-co-infected subjects than in HCV-mono-infected subjects (Table S2 , Fig. S4 ).
The effect of HIV co-infection on the association between the markers described above and HCV vl was assessed by adding an interaction term to the already described models. Significant interactions were found for NK cell-associated variables, but not for T cells.
More precisely, the model suggests that the association between HCV co-infected in contrast to HCV mono-infected (Table S2 , Fig.   S4 ), possibly as a result of ART-mediated immune reconstitution.
Taken together, these findings support that increasing HCV viraemia is associated with a greater degree of NK cell activation and dysfunction in ART-treated HIV-co-infected/untreated HCV subjects than in untreated HCV viraemic mono-infected subjects.
| DISCUSSION
We HIV/HCV-co-infected subjects have been reported to have high levels of immune activation, particularly T-cell activation (ie CD38, HLA-DR), even in the presence of suppressive ART. [35] [36] [37] [38] In this study,
we confirmed higher levels of T-cell activation, and also observed higher levels of markers of T-cell exhaustion in ART-treated HIV/ HCV-co-infected subjects, as noted by the higher expression of CD160 and other exhaustion markers on CD8 + T cells. Linear regression models further supported these results by showing an effect of patient group but not of HCV vl on T-cell activation/exhaustion markers, with HIV/HCV-co-infected subjects having higher levels of T-cell activation/exhaustion. These results are overall in agreement with the findings by Feuth et al., 48 suggesting an increased exhaustion in HCV viraemic/HIV-co-infected subjects on ART, despite the fact that in our study, subjects with established noncompensated cirrhosis were excluded. T A B L E 3 Linear models using HCV vl (log10 copies/mL) and patient group as predictors of immune variables the study groups limiting the secondary effects of ethnicity or noncompensated cirrhosis. On the other hand, the lack of HCV-specific T-cell responses restricting our findings as non-HCV specific is a limitation of our study. However, it has been suggested that nonspecific activation may affect disease progression, as liver infiltrates are largely composed of HCV nonspecific T cells. 61, 62 Another limitation of our study is the lack of an ART-treated HIV/HCV uninfected control group to address direct differences in ART-mediated immune reconstitution with HIV/HCV-co-infected subjects in the presence of HCV viraemia.
However, while the association between CD4 + T-cell count and T-cell activation was significantly different between the two groups, no association between CD4 + T-cell count and NK markers was observed in either group suggesting that the level of CD4 
